HOME > TOP STORIES
TOP STORIES
-
REGULATORY Japan Panel to Review AbbVie’s Aquipta, Ipsen’s Sohonos on January 23
January 13, 2026
-
REGULATORY MHLW Pharma Director Says Uniform Drug Price Hike “Not Realistic,” Targeted Support Preferred
January 9, 2026
-
BUSINESS Bayer/Santen to Launch Eylea Bio-AG on February 2
January 9, 2026
-
BUSINESS Pharma Leaders Press for Drug Pricing Overhaul at New Year’s Confab
January 8, 2026
-
BUSINESS Generic Entry into DPP-4 Class Poised to Accelerate in 2026
January 7, 2026
-
COMMENTARY Wave of “World Firsts” Looms as 47 New Drug Candidates Line Up for 2026
January 6, 2026
-
ORGANIZATION FY2026 Reform Tilted toward Price Cuts despite Spillover Scrap: FPMAJ Chair
January 6, 2026
-
ORGANIZATION Pfizer Japan President Igarashi Takes Helm as PhRMA Japan Chair
January 6, 2026
-
ORGANIZATION Industry Leaders Call for Proper Rewards for Innovation in New Year Messages
January 5, 2026
-
REGULATORY Gist of FY2026 Drug Pricing Reform Outline
December 26, 2025
-
REGULATORY Japan Puts CEA Expansion on Hold, Sets 6-Month “Technical Discussions”
December 26, 2025
-
REGULATORY Chuikyo OKs FY2026 Drug Pricing Reform Outline, Scraps “Spillovers” but Adds New Follow-Up Rules
December 26, 2025
-
REGULATORY MHLW Names 77 Active Ingredients for OTC-Like Drug Charges
December 26, 2025
-
REGULATORY Japan Ministers Agree to Scrap “Spillover” Rule, Plan Wider CEA Price Cuts
December 25, 2025
-
REGULATORY Japan Weighs Scrapping “Spillover” Rule in Shift from Draft Reform Outline
December 24, 2025
-
BUSINESS Cyto-Facto Expands CPC Footprint to Win Multiple Cell Therapy Contracts
December 24, 2025
-
REGULATORY Japan Approves Batch of New Drugs, Subcutaneous Rybrevant Finally Cleared
December 23, 2025
-
TRENDS Top 10 PHARMA JAPAN Articles of 2025
December 23, 2025
-
REGULATORY LDP, Ishin Strike Deal on OTC-Like Drugs, Patients to Pay “1/4” Special Charge
December 22, 2025
-
REGULATORY LDP, Ishin Finalize FY2026 Tax Reform Outline, Strategic Tech R&D Credit Codified
December 22, 2025
ページ
Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…
